These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3427340)

  • 1. Basement membranes in urothelial carcinoma.
    Conn IG; Crocker J; Wallace DM; Hughes MA; Hilton CJ
    Br J Urol; 1987 Dec; 60(6):536-42. PubMed ID: 3427340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunocytochemical demonstration of basement membrane deposition in transitional cell carcinoma of bladder.
    Zuk RJ; Baithun SI; Martin JE; Cox EL; Revell PA
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):447-52. PubMed ID: 2499101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin--a basement membrane specific glycoprotein--in bladder carcinomas.
    Hashimoto H; Sakashita S
    Urol Int; 1986; 41(4):248-53. PubMed ID: 3787845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder.
    Schapers RF; Pauwels RP; Havenith MG; Smeets AW; van den Brandt PA; Bosman FT
    Cancer; 1990 Dec; 66(12):2583-8. PubMed ID: 2249199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen IV staining pattern in bladder carcinomas: relationship to prognosis.
    Daher N; Abourachid H; Bove N; Petit J; Burtin P
    Br J Cancer; 1987 Jun; 55(6):665-71. PubMed ID: 3304387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
    Abou Farha KM; Janknegt RA; Kester AD; Arends JW
    Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basement membrane and tumor invasion: ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Zhang XH; Takenaka I
    Urol Res; 1994; 22(5):317-21. PubMed ID: 7879318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
    Deen S; Ball RY
    Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of basement membranes in primary and metastatic carcinomas of the prostate.
    Bonkhoff H; Wernert N; Dhom G; Remberger K
    Hum Pathol; 1992 Aug; 23(8):934-9. PubMed ID: 1644438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.
    Lipponen PK
    J Cancer Res Clin Oncol; 1993; 119(5):295-300. PubMed ID: 7680044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultrastructural and morphometric study of bladder tumours (II).
    Smith AF
    Virchows Arch A Pathol Anat Histol; 1982 Aug; 396(3):291-301. PubMed ID: 7135825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopy of superficial bladder tumours and urothelium after intravesical doxorubicin.
    Wisniewski S; Knowles JC; Cooper EH
    Eur Urol; 1982; 8(6):351-7. PubMed ID: 7140785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
    Soini Y; Turpeenniemi-Hujanen T; Kamel D; Autio-Harmainen H; Risteli J; Risteli L; Nuorva K; Pääkkö P; Vähäkangas K
    Br J Cancer; 1993 Nov; 68(5):1029-35. PubMed ID: 8217593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of basement membrane antigens in bladder carcinomas: an additional prognostic parameter. Immunohistochemical study.
    Alampi G; Gelli C; Mestichelli M; Brizio R; Piccaluga A
    Arch Anat Cytol Pathol; 1989; 37(5-6):224-30. PubMed ID: 2604440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laminin (a basement membrane-specific glycoprotein) in bladder carcinomas].
    Hashimoto H; Kuroda K; Sakashita S
    Nihon Hinyokika Gakkai Zasshi; 1984 Apr; 75(4):580-90. PubMed ID: 6482108
    [No Abstract]   [Full Text] [Related]  

  • 16. A cytologic, ultrastructural and immunocytochemical comparison of tumor cells and cell cultures originating in invasive bladder carcinoma.
    Logothetou-Rella H; Karayiannis A; Vamvassakis E; Livaditou A; Pikramenos D; Nesland JM; Dimopoulos C
    Eur Urol; 1992; 21(2):146-50. PubMed ID: 1379923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological changes in the basement membrane during progression from non-invasive to invasive rat bladder cancer induced by N-butyl-N-(4-hydoxybutyl) nitrosamine.
    Zhang XH; Takenaka I
    Br J Urol; 1997 Mar; 79(3):378-82. PubMed ID: 9117217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the laminin immunohistochemical stain in distinguishing invasive from noninvasive urothelial carcinoma.
    Pradhan D; Amin M; Hooda S; Dhir R; Bastacky S; Parwani AV
    J Cancer Res Ther; 2017; 13(6):947-950. PubMed ID: 29237956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular architecture of papillary and nonpapillary transitional cell carcinoma].
    Moriyama M
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1017-24. PubMed ID: 2607715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural observations on 10 cases of transitional cell carcinoma of the human bladder].
    Liu J; Zhou KZ
    Zhonghua Bing Li Xue Za Zhi; 1986 Sep; 15(3):220-2. PubMed ID: 2953464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.